BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 16229956)

  • 1. I.V. infusion of brain-derived neurotrophic factor gene-modified human mesenchymal stem cells protects against injury in a cerebral ischemia model in adult rat.
    Nomura T; Honmou O; Harada K; Houkin K; Hamada H; Kocsis JD
    Neuroscience; 2005; 136(1):161-9. PubMed ID: 16229956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Administration of mesenchymal stem cells and ziprasidone enhanced amelioration of ischemic brain damage in rats.
    Kaengkan P; Baek SE; Kim JY; Kam KY; Do BR; Lee ES; Kang SG
    Mol Cells; 2013 Dec; 36(6):534-41. PubMed ID: 24292945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rehabilitation facilitates functional improvement following intravenous infusion of mesenchymal stem cells in the chronic phase of cerebral ischemia in rats.
    Yamashita T; Sasaki M; Sasaki Y; Nagahama H; Oka S; Kataoka-Sasaki Y; Ukai R; Yokoyama T; Kobayashi M; Kakizawa M; Kocsis JD; Honmou O
    Brain Res; 2024 Feb; 1825():148709. PubMed ID: 38072373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p5 Peptide-Loaded Human Adipose-Derived Mesenchymal Stem Cells Promote Neurological Recovery After Focal Cerebral Ischemia in a Rat Model.
    Paudyal A; Ghinea FS; Driga MP; Fang WH; Alessandri G; Combes L; Degens H; Slevin M; Hermann DM; Popa-Wagner A
    Transl Stroke Res; 2021 Feb; 12(1):125-135. PubMed ID: 32378028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pioglitazone treatment prior to transplantation improves the efficacy of human mesenchymal stem cells after traumatic brain injury in rats.
    Das M; Mayilsamy K; Tang X; Han JY; Foran E; Willing AE; Mohapatra SS; Mohapatra S
    Sci Rep; 2019 Sep; 9(1):13646. PubMed ID: 31541141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential optimized route for mesenchymal stem cell transplantation in a rat model of cerebral palsy.
    Huang S; Liu L; Huang Y; Fu C; Peng T; Yang X; Zhou H; Zhao Y; Xu Y; Zeng X; Zeng P; Tang H; He L; Xu K
    Exp Cell Res; 2023 Sep; 430(2):113734. PubMed ID: 37532123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Precisely targeted drug delivery by mesenchymal stem cells-based biomimetic liposomes to cerebral ischemia-reperfusion injured hemisphere.
    Dong YF; Li YS; Liu H; Li L; Zheng JJ; Yang ZF; Sun YK; Du ZW; Xu DH; Li N; Jiang XC; Gao JQ
    J Control Release; 2024 Jun; 371():484-497. PubMed ID: 38851537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Can Mesenchymal Stem Cell-Derived Therapeutics Protect the Developing Brain During Cardiac Surgery?
    Hansmann G
    JACC Basic Transl Sci; 2023 Dec; 8(12):1536-1538. PubMed ID: 38205354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimization of a therapeutic protocol for intravenous injection of human mesenchymal stem cells after cerebral ischemia in adult rats.
    Omori Y; Honmou O; Harada K; Suzuki J; Houkin K; Kocsis JD
    Brain Res; 2008 Oct; 1236():30-8. PubMed ID: 18722359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous administration of glial cell line-derived neurotrophic factor gene-modified human mesenchymal stem cells protects against injury in a cerebral ischemia model in the adult rat.
    Horita Y; Honmou O; Harada K; Houkin K; Hamada H; Kocsis JD
    J Neurosci Res; 2006 Nov; 84(7):1495-504. PubMed ID: 16998918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroprotection by PlGF gene-modified human mesenchymal stem cells after cerebral ischaemia.
    Liu H; Honmou O; Harada K; Nakamura K; Houkin K; Hamada H; Kocsis JD
    Brain; 2006 Oct; 129(Pt 10):2734-45. PubMed ID: 16901914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of colchicine on platelet aggregation in patients on dual antiplatelet therapy with aspirin and clopidogrel.
    Cirillo P; Taglialatela V; Pellegrino G; Morello A; Conte S; Di Serafino L; Cimmino G
    J Thromb Thrombolysis; 2020 Aug; 50(2):468-472. PubMed ID: 32335777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thieno[2,3-b]pyridine derivatives are potent anti-platelet drugs, inhibiting platelet activation, aggregation and showing synergy with aspirin.
    Binsaleh NK; Wigley CA; Whitehead KA; van Rensburg M; Reynisson J; Pilkington LI; Barker D; Jones S; Dempsey-Hibbert NC
    Eur J Med Chem; 2018 Jan; 143():1997-2004. PubMed ID: 29129512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A rabbit model of cerebral microembolic signals for translational research: preclinical validation for aspirin and clopidogrel.
    Zhou X; Kurowski S; Wu W; Desai K; Chu L; Gutstein DE; Seiffert D; Wang X
    J Thromb Haemost; 2016 Sep; 14(9):1855-66. PubMed ID: 27262051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human mesenchymal stem cell culture for neural transplantation.
    Gordon D; Scolding NJ
    Methods Mol Biol; 2009; 549():103-18. PubMed ID: 19378199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neural differentiation potential of peripheral blood- and bone-marrow-derived precursor cells.
    Kim S; Honmou O; Kato K; Nonaka T; Houkin K; Hamada H; Kocsis JD
    Brain Res; 2006 Dec; 1123(1):27-33. PubMed ID: 17064670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic benefits of angiogenetic gene-modified human mesenchymal stem cells after cerebral ischemia.
    Toyama K; Honmou O; Harada K; Suzuki J; Houkin K; Hamada H; Kocsis JD
    Exp Neurol; 2009 Mar; 216(1):47-55. PubMed ID: 19094989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mesenchymal stem cell therapy for ischemic stroke: Novel insight into the crosstalk with immune cells.
    Tan N; Xin W; Huang M; Mao Y
    Front Neurol; 2022; 13():1048113. PubMed ID: 36425795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autologous Genetically Enriched Leucoconcentrate in the Preventive and Acute Phases of Stroke Treatment in a Mini-Pig Model.
    Safiullov Z; Izmailov A; Sokolov M; Markosyan V; Kundakchan G; Garifulin R; Shmarov M; Naroditsky B; Logunov D; Islamov R
    Pharmaceutics; 2022 Oct; 14(10):. PubMed ID: 36297644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Shh and Olig2 sequentially regulate oligodendrocyte differentiation from hiPSCs for the treatment of ischemic stroke.
    Xu J; Zhao J; Wang R; Zhang Y; Shen L; Xiao Q; Xie Y; Jiang J; Nie Y; Deng W
    Theranostics; 2022; 12(7):3131-3149. PubMed ID: 35547747
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.